— Know what they know.
Not Investment Advice

BNYN OTC

Banyan Corp.
1W: -99.5% 1M: -99.5% 3M: -99.5% YTD: -99.5% 1Y: -99.5% 3Y: -99.0% 5Y: -99.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±9455.5%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 45 · $286042 mcap · 787M float · 0.0014% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.3M
52W Range0.000001-0.000190000006
Volume5
Avg Volume11,123
Beta-4.62
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael J. Gelmon
Employees20
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2002-03-07
9025 Wilshire Boulevard
Beverly Hills, CA 90211
US
800-808-0899
About Banyan Corp.

Banyan Corp., operating through its subsidiaries, focuses on franchising chiropractic clinics throughout North America. The company provides extensive support to its franchisees and licensees, including specialized practice development training and assistance tailored for chiropractors. Beyond its franchising activities, Banyan delivers vital diagnostic testing services. A key offering is Nerve Conduction Velocity (NCV) testing, which is administered to patients via healthcare professionals such as doctors and chiropractors. This NCV testing is instrumental in evaluating the transmission of nerve impulses, identifying irregularities within the nervous system, and supplying objective data to substantiate treatment expenses for patients and their insurance providers. Furthermore, Banyan manufactures and markets its proprietary VT3000, an advanced nerve testing system. This system is engineered for the precise diagnosis of neuropathies – conditions affecting the peripheral nerves and spinal regions – alongside nerve irritation and other forms of nervous system damage in patients. Established in 1978, Banyan Corp. maintains its headquarters in Beverly Hills, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms